Yumove

YuMOVE products are available in several pharmaceutical forms and nutritional formulas, tailored to the specific needs of dogs. The most common forms are:

• Chewable tablets for joints, such as YuMOVE Joint Care Senior Dogs or YuMOVE Advance
• Liquid supplements for skin and coat, such as YuMOVE Skin & Coat Care
• Probiotic tablets for digestion, such as YuMOVE Digestive Care

YuMOVE supplements for dogs are recommended in numerous clinical or physiological situations and are frequently used as a nutritional aid in veterinary medicine.

In the case of products designed for joints, these are recommended for:

• senior dogs with joint stiffness or reduced mobility;
• animals with osteoarthritis or cartilage degeneration;
• active or sporting dogs prone to joint strain.

YuMOVE Digestive Care supplements are useful in situations such as:

• digestive disorders in dogs with sensitive stomachs;
• occasional diarrhoea;
• intestinal dysbiosis following antibiotic treatment.

The dosage of YuMOVE dog products depends on the type of supplement and the dog’s weight.

For YuMOVE Joint Care Senior Dog, dogs weighing under 15 kg receive 1 tablet per day, those between 16 and 30 kg receive 2 tablets per day, dogs between 31 and 45 kg receive 3 tablets per day, and dogs over 45 kg receive 4 tablets per day.

For YuMOVE Digestive Care, dogs weighing under 10 kg receive 1 tablet per day, those between 11 and 25 kg receive 2 tablets per day, dogs between 26 and 40 kg receive 3 tablets per day, and dogs over 40 kg receive 4 tablets per day.

YuMOVE dog supplements are generally well tolerated, but should be administered with caution in certain situations. They are not recommended:

• in cases of hypersensitivity to shellfish or marine ingredients;
• in dogs with severe food allergies to the product’s ingredients;
• without a vet’s recommendation for animals with complex metabolic conditions.

Furthermore, use in pregnant or lactating bitches should only be carried out on the advice of a vet.

An important feature of YuMOVE supplements is the high bioavailability of the active ingredients. GLM Active Ease green-lipped mussel extract, obtained through special processing methods, contains high concentrations of omega-3 fatty acids with anti-inflammatory properties.

In the case of digestive products, the combination of probiotics (Enterococcus faecium) and prebiotics (MOS, FOS, beta-glucans) creates a gut environment favourable to beneficial bacteria, helping to stabilise the microflora.

Adverse effects associated with taking YuMOVE products are rare and, as a rule, mild. Occasionally, the following may occur:

• temporary digestive disturbances (flatulence, loose stools);
• allergic reactions to marine-derived ingredients;
• temporary loss of appetite at the start of treatment.

In most cases, these reactions are self-limiting and disappear once the body has adapted.

YuMOVE products can be administered alongside most commercial diets and other nutritional supplements.

No significant drug interactions have been reported; however, it is recommended that you consult your vet if your pet is undergoing complex treatment.

Accidental overdose is unlikely to cause severe effects, as most of the ingredients are natural nutrients.

However, administering excessive amounts may cause digestive disturbances, such as diarrhoea or abdominal discomfort. In such situations, it is recommended to temporarily discontinue administration and monitor the animal.

YuMOVE supplements should be stored in their original packaging, at temperatures below 25°C, in a dry place away from light.

It is important that the product is kept out of reach of children and animals, and that the bottle is closed properly after each use to prevent the active ingredients from degrading.

• PubMed, The use of glucosamine and chondroitin in dogs for the treatment of osteoarthritis: a review
• PubMed, Microbiota and probiotics in the well-being of dogs and cats
• MDPI, The effect of a supplement containing probiotics, prebiotics and yeast extract on intestinal inflammation, microbiota and cytokines in healthy dogs
• MDPI, Glucosamine and chondroitin sulphate: is there scientific evidence for their efficacy as disease-modifying drugs in preclinical studies of knee osteoarthritis? — A systematic review from 2000–2021